You must have an account with AABS, be logged in, and be registered as a faculty member to search the faculty database.

Case Study: GLAXOSMITHKLINE AND AIDS DRUGS IN SOUTH AFRICA (C): THE FIGHT GOES ON

Title
GLAXOSMITHKLINE AND AIDS DRUGS IN SOUTH AFRICA (C): THE FIGHT GOES ON 

Author
Yaziji, M ; Lindblom, A 

Pages

Product Type
 

Reference #
IMD-3-1498 

Teaching Note
 

Institute

Setting
 

Year
 

Keywords
Non-government organisations (NGO's) ; Non-market competition ; Ethics ; Pharmaceutical ; AIDS ; Patents; South Africa; Pharmaceutical; Largest pharmaceutical company in the world, more than 100,000 employees; 2001-2004



Summary/
Abstract
This is the third of a four-case series (IMD-3-1496 to IMD-3-1499). The (C) part of the series focuses on the actions GlaxoSmithKline (GSK) had to take after being pressured by the non-government organisations (NGO's). The company had been defeated and it agreed to several licensing agreements and price reductions, but the NGO's are still not satisfied. The topic was also gaining importance in the Western media and the big question now was whether it was starting to become an issue in more developed countries, where the vast majority of GSKs' sales and profits were being made.

 


The Impact of AABS Video

"The impact of AABS Video" was filmed at the Gordon Institute of Business Science, Johannesburg and at the University of Cape Town Graduate School of Business, Cape Town during the AABS Members Meeting and Conference 2011.

 

View The Imact of AABS Video

AABS is proud to announce our new project: African Agribusines Network (AAgri.net). Visit the website.

Reports on the AABS Members Meeting 2011 and Responsible Management in Africa Conference 2011